Quarterly Consolidated Balance Sheet

BrightPath Biotherapeutics Co., Ltd. - Filing #7302244

Concept As at
2024-09-30
As at
2024-03-31
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,539,394,000 JPY
1,057,360,000 JPY
Other
107,502,000 JPY
123,594,000 JPY
Current assets
1,646,927,000 JPY
1,180,960,000 JPY
Non-current assets
Property, plant and equipment
0 JPY
0 JPY
Property, plant and equipment
Intangible assets
Intangible assets
0 JPY
0 JPY
Investments and other assets
49,296,000 JPY
49,296,000 JPY
Investments and other assets
Non-current assets
49,296,000 JPY
49,296,000 JPY
Assets
1,696,224,000 JPY
1,230,257,000 JPY
Liabilities
Current liabilities
Income taxes payable
12,436,000 JPY
12,815,000 JPY
Other
60,302,000 JPY
65,675,000 JPY
Current liabilities
397,755,000 JPY
191,011,000 JPY
Non-current liabilities
Asset retirement obligations
22,694,000 JPY
22,648,000 JPY
Other
0 JPY
0 JPY
Non-current liabilities
64,361,000 JPY
60,258,000 JPY
Liabilities
462,117,000 JPY
251,270,000 JPY
Net assets
Shareholders' equity
Share capital
1,047,921,000 JPY
650,661,000 JPY
Capital surplus
3,356,455,000 JPY
2,959,195,000 JPY
Retained earnings
-3,192,452,000 JPY
-2,653,715,000 JPY
Treasury shares
0 JPY
0 JPY
Shareholders' equity
1,211,925,000 JPY
956,141,000 JPY
Share acquisition rights
22,182,000 JPY
22,845,000 JPY
Net assets
1,234,107,000 JPY
978,987,000 JPY
Liabilities and net assets
1,696,224,000 JPY
1,230,257,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.